Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

Market Cap	4.75B +9.3%
Revenue (ttm)	2.27B -19.7%
Net Income	222.85M +1.0%
EPS	0.32 +4.8%
Shares Out	692.00M
PE Ratio	21.72
Forward PE	n/a
Dividend	0.40 (5.91%)
Ex-Dividend Date	Feb 6, 2026

Volume	13,020,467
Average Volume	13,020,516
Open	6.77
Previous Close	6.77
Day's Range	6.75 - 6.86
52-Week Range	5.35 - 8.68
Beta	0.07
RSI	57.51
Earnings Date	Apr 25, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 3,611
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600351

Financial Performance

In 2024, SHA:600351's revenue was 2.69 billion, a decrease of -7.69% compared to the previous year's 2.91 billion. Earnings were 242.69 million, an increase of 21.60%.